At the Rachel Lindsay Foundation For Women’s Orthopedic Health our vision is to improve the quality of life for women who are generally at higher risk of hip revision surgery.
Our mission is to fund the engineering and rigorous FDA, IDE, and Pre-market Approval via “prove a truth” testing of gender specific orthopedic solutions that would otherwise never come to market. That involves a patient Pilot Study then at least a two year-follow up.
We attend annually the CCJR Current Concepts in Joint Replacement conference to hear of the current problems in orthopedics, and the AAOS American Academy of Orthopedic Surgeons trade show to seek any form of women specific orthopedic devices that have no predicate. This includes spine, shoulders, knees and hip orthopedic devices.
Great news! We are no longer searching for a cure for hip ‘revision’ surgery. We are 99% sure we found the solution. The last 1% is FDA/PMA approval. During patent searches we discovered this new revolutionary medical device - the Frictionless Hip Implant (#2020/0222197, U.S.#10,596,005).
Our purpose is to prove that this gender-specific frictionless device has better results for women when compared to current unisex devices.
